Page last updated: 2024-12-04

benzyl isothiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2346
CHEMBL ID55285
CHEBI ID17484
SCHEMBL ID44145
MeSH IDM0098685

Synonyms (121)

Synonym
ab 2
nsc118976
isothiocyanic acid, benzyl ester
urogran
tromalyt
nsc-118976
benzylisothiocyanate
benzylsenfoel
wln: scn1r
toluene, .alpha.-isothiocyanato-
tromacaps
benzene, (isothiocyanatomethyl)-
(isothiocyanatomethyl)benzene
alpha-isothiocyanatotoluene
CHEBI:17484 ,
DIVK1C_006780
NCIMECH_000859
SDCCGMLS-0066697.P001
isothiocyanic acid benzyl ester
ccris 3145
einecs 210-753-9
benzylsenfoel [german]
nsc 118976
brn 0386135
ab 2 (van)
benzyl-isothiocyanate ,
ai3-02736
toluene, alpha-isothiocyanato-
SPECTRUM_001820
BSPBIO_002526
SPECTRUM5_001837
QTL1_000013
benzyl isothiocyanate
C03098
622-78-6
benzyl isothiocyanate, 98%
NCGC00094982-01
NCGC00094982-02
NCI60_000455
KBIOGR_001358
KBIO3_001746
KBIO2_007457
KBIOSS_002323
KBIO2_004889
KBIO1_001724
KBIO2_002321
SPECTRUM2_000852
SPECTRUM3_000793
SPECTRUM4_001059
SPECPLUS_000684
SPBIO_000863
SPECTRUM1503006
NCGC00094982-03
bitc
pmitc cpd
phenylmethyl isothiocyanate
STK399787
bdbm50240520
bitc, 17
AKOS000212138
isothiocyanatomethylbenzene
isothiocyanatomethyl-benzene
CHEMBL55285 ,
I0224
HMS1921P18
A833692
NCGC00094982-04
cas-622-78-6
dtxsid0020155 ,
tox21_201191
NCGC00258743-01
dtxcid60155
BBL013129
nsc-758206
pharmakon1600-01503006
nsc758206
CCG-35868
isothiocyanotaomethylbenzene
unii-871j6yor8q
871j6yor8q ,
4-12-00-02276 (beilstein handbook reference)
BP-12924
FT-0622167
S4783
benzyl isothiocyanate [fhfi]
1-(isothiocyanatomethyl)benzene
isothiocyanatomethyl)benzene
fema no. 4428
benzylisothiocyanate [who-dd]
benzyl isothiocyanate [mart.]
(isothiocyanatomethyl)-benzene
SCHEMBL44145
J-650076
(isothiocyanatomethyl)benzene #
AB00053249_03
mfcd00004819
F0001-1663
benzyl isothiocyanate, analytical standard
SR-05000002381-2
sr-05000002381
SR-05000002381-1
benzyl isothiocyanate, 98%, fg
tromalyt active substance
alpha-isothiocyanato-toluene
tromocaps
benzyl isothio cyanate
isothiocyanato-methyl-benzene
toluene, alpha -isothiocyanato-
(isothiocyanatomethyl)benzene, 9ci
benzylsenfoel (german)
SBI-0052749.P002
HY-77813
F16583
Q18341725
PS-10308
CS-0006958
PB43176
EN300-17059
benzyl isothiocyanate (mart.)
SY010809
Z56869309

Research Excerpts

Overview

Benzyl isothiocyanate (BITC) is a naturally occurring compound found in cruciferous vegetables, and exhibits potential as a chemopreventive agent. BITC has been shown to have anti-tumor properties in xenograft and transgenic mouse models.

ExcerptReferenceRelevance
"Benzyl isothiocyanate (BITC) is an organosulfur compound derived from cruciferous vegetables and papaya seeds. "( Benzyl isothiocyanate ameliorates lipid accumulation in 3T3-L1 preadipocytes during adipocyte differentiation.
Liang, Y; Munemasa, S; Murata, Y; Nakamura, T; Nakamura, Y; Sasaki, I; Takeda, Y; Zhu, B, 2018
)
3.37
"Benzyl isothiocyanate (BITC) is a member of the isothiocyanate compounds that found in cruciferous vegetables. "( Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF.
Helmy, MW; Omran, G; Salahuddin, A; Zakaria, S, 2018
)
1.92
"Benzyl isothiocyanate (BITC) is a naturally-occurring isothiocyanate derived from cruciferous vegetables. "( Yeast screening system reveals the inhibitory mechanism of cancer cell proliferation by benzyl isothiocyanate through down-regulation of Mis12.
Abe-Kanoh, N; Chino, A; Kunisue, N; Moriya, H; Munemasa, S; Murata, Y; Myojin, T; Nakamura, Y; Satoh, A, 2019
)
2.18
"Benzyl isothiocyanate (BITC) is a hydrolysis product of glucotropaeolin, a compound found in cruciferous vegetables, and has been shown to have anti-tumor properties. "( Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest.
Cho, HJ; Dong, Z; Huang, Z; Kang, YH; Kim, JH; Kwon, GT; Lee, KW; Lim, DY; Oh, YS; Park, JH; Song, H, 2016
)
3.32
"Benzyl isothiocyanate (BITC) is a highly promising phytochemical abundant in cruciferous vegetables with preclinical evidence of in vivo efficacy against breast cancer in xenograft and transgenic mouse models. "( Inhibition of mitochondrial fusion is an early and critical event in breast cancer cell apoptosis by dietary chemopreventative benzyl isothiocyanate.
Baty, CJ; Croix, CS; Sehrawat, A; Singh, RP; Singh, SV; Tailor, D; Watkins, S, 2016
)
2.08
"Benzyl isothiocyanate (BITC) is a naturally occurring compound found in cruciferous vegetables, and BITC exhibits potential as a chemopreventive agent."( Benzyl isothiocyanate inhibits inflammasome activation in E. coli LPS-stimulated BV2 cells.
Choi, IW; Choi, JS; Choi, YH; Jung, WK; Lee, CM; Lee, DS; Lee, YM; Park, S; Park, WS; Seo, SK; Yim, MJ; Yoo, JS, 2016
)
2.6
"Benzyl isothiocyanate (BITC) is a dietary isothiocyanate derived from cruciferous vegetables. "( Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.
Chen, Y; Dong, X; Guo, J; Li, M; Li, W; Lin, B; Lu, Y; Zhang, X; Zhu, M, 2016
)
2.17
"Benzyl isothiocyanate (BITC) is a hydrolysis compound of glucotropaeolin in dietary cruciferous vegetables."( Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
Chung, JG; Ho, CC; Hsu, SC; Kuo, CL; Lai, KC; Lin, ML; Ma, CY; Yang, JS, 2011
)
2.53
"Benzyl isothiocyanate (BITC) is an important compound found in plant food and has been shown to have anti-cancer effects on human cancer cells, but its effect on prostate cancer cells in vitro remains unknown."( The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway.
Chiu, TH; Chueh, FS; Chung, JG; Huang, YT; Ji, BC; Liu, KC; Wu, PP; Yang, JL; Yang, JS, 2011
)
1.34
"Benzyl isothiocyanate (BITC) is a promising anticancer constituent of edible cruciferous vegetables with in vivo efficacy against chemically induced as well as oncogene-driven breast cancer in experimental rodents. "( Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Kim, SH; Sehrawat, A; Singh, SV, 2012
)
2.14
"Benzyl isothiocyanate (BITC) is a promising chemopreventive agent found in cruciferous vegetables and papaya fruits."( Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells.
Choi, YJ; Chung, HW; Kim, YJ; Lee, JW; Lee, S; Lee, Y, 2012
)
1.37
"Benzyl isothiocyanate (BITC) is a dietary chemopreventive agent that inhibits the growth of various human cancer cells by causing apoptotic cell death. "( Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling.
Chen, HE; Chou, KY; Hwang, TI; Liao, PC; Lin, JF; Lin, YC; Lin, YH; Tsai, TF, 2013
)
3.28
"Benzyl isothiocyanate (BITC) is a hydrolysis compound of glucotropaeolin in cruciferous vegetables. "( Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
Hwang, ES; Lee, HJ, 2008
)
3.23

Effects

Benzyl isothiocyanate (BITC) has been shown to inhibit chemically induced pancreatic cancer in experimental animals. It has been reported to exhibit antitumor properties in various cancer types. The underlying mechanisms of its action remain unclear.

ExcerptReferenceRelevance
"Benzyl isothiocyanate (BITC) has been shown to inhibit invasion and induce apoptosis of various types of cancer. "( Benzyl isothiocyanate inhibits invasion and induces apoptosis via reducing S100A4 expression and increases PUMA expression in oral squamous cell carcinoma cells.
Chen, Y; Han, R; Ma, L; Wang, S, 2019
)
3.4
"Benzyl isothiocyanate (BITC) has been reported to exhibit antitumor properties in various cancer types; however, the underlying mechanisms of its action remain unclear. "( Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway.
Chen, J; Fan, L; Fan, W; Fu, S; Guo, L; Lin, L; Liu, H; Wang, B; Wei, H; Xie, B; Zhao, L, 2019
)
3.4
"Benzyl isothiocyanate (BITC) has been shown to have inhibitory potential for human glioma U87MG cells; however, the effect and mechanism were not fully clear. "( The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.
Liu, A; Liu, Y; Qi, L; Xue, J; Yang, P; Zhang, L; Zhang, X; Zhu, Y, 2015
)
2.22
"Benzyl isothiocyanate (BITC) has been shown to inhibit chemically induced pancreatic cancer in experimental animals. "( Benzyl isothiocyanate-induced DNA damage causes G2/M cell cycle arrest and apoptosis in human pancreatic cancer cells.
Humphreys, I; Loganathan, S; Srivastava, SK; Zhang, R, 2006
)
3.22

Treatment

Benzyl isothiocyanate (BITC) treatment down-regulates cyclins and CDKs. Up-regulate the expression of the CDK inhibitor p21, but up-regulation of p27 or p53 was not detected.

ExcerptReferenceRelevance
"Benzyl isothiocyanate (BITC) treatment down-regulates cyclins and CDKs and up-regulates the expression of the CDK inhibitor p21, but up-regulation of p27 or p53 was not detected."( A novel function of benzyl isothiocyanate in vascular smooth muscle cells: the role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9.
Hwang, CW; Kim, CH; Kim, MG; Kim, YK; Lee, JY; Moon, SK; Nam, KS; Yoon, HD, 2005
)
1.37
"In benzyl isothiocyanate-treated animals, an induction of subunit 3 was found as well as an increase in the relative amount of subunit 2."( Differential induction of rat hepatic glutathione S-transferase isoenzymes by hexachlorobenzene and benzyl isothiocyanate. Comparison with induction by phenobarbital and 3-methylcholanthrene.
Müller, F; Snoek, MC; van Berkel, WJ; van Bladeren, PJ; Vos, RM, 1988
)
1.01

Toxicity

ExcerptReferenceRelevance
" Both types of conjugates caused considerable toxicity: allyl isothiocyanate conjugates gave effects comparable to the parent compound, but benzyl isothiocyanate was more toxic than its conjugates."( Glutathione- and cysteine-mediated cytotoxicity of allyl and benzyl isothiocyanate.
Bruggeman, IM; Temmink, JH; van Bladeren, PJ, 1986
)
0.71
" It is proposed that the presence of such selectively toxic compounds in the diet may inhibit the development of tumors by interfering with the growth of preneoplastic lesions while having little effect on normal cells."( Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29.
Fyfe, D; Johnson, IT; Musk, SR; Smith, TK; Stening, P; Stephenson, P, 1995
)
0.29
" To elucidate direct toxic effects of isothiocyanates (ITCs), BITC, AITC, or BITC-metabolites conjugated either with glutathione, cysteinylglycine, cysteine, or mercapturic acid were intravesically instilled into female F344 rats."( Toxic effects of benzyl and allyl isothiocyanates and benzyl-isoform specific metabolites in the urinary bladder after a single intravesical application to rats.
Hirose, M; Masutomi, N; Niho, N; Shibutani, M; Takahashi, N; Toyoda, K; Uneyama, C,
)
0.13
"Natural isothiocyanates (ITCs) are toxic to a range of pathogenic soil-living species, including nematodes and fungi, and can thus be used as natural fumigants called biofumigants."( The toxic effects of benzyl glucosinolate and its hydrolysis product, the biofumigant benzyl isothiocyanate, to Folsomia fimetaria.
Bruun Hansen, HC; Gimsing, AL; Jensen, J; Styrishave, B, 2010
)
0.58

Bioavailability

ExcerptReferenceRelevance
" For example, a reaction of ITC with nucleophilic amino acid side chains of proteins such as cysteine and lysine can occur, reducing the bioavailability of indispensable amino acids and protein functions may be altered."( Determination of isothiocyanate-protein conjugates in milk and curd after adding garden cress (Lepidium sativum L.).
Hanschen, FS; Kühn, C; Rohn, S; von Oesen, T, 2018
)
0.48
"49%), and the retention rate and bioavailability of BITC from the PRPI-corn emulsion were 75."( Pseudosciaena crocea roe protein-stabilized emulsions for oral delivery systems: In vitro digestion and in situ intestinal perfusion study.
Cui, H; Jiang, H; Lin, S; Song, L; Tang, Y; Wang, X; Zhang, Z, 2020
)
0.56
"LUT could form stable complexes with FSG, which improved the stability and bioavailability of BITC in the FSG-LUT emulsion delivery system, and promoted further intestinal BITC absorption."( Construction of benzyl isothiocyanate-loaded fish skin gelatin-luteolin compound emulsion delivery system, and its digestion and absorption characteristics.
Lin, S; Liu, W; Liu, Z; Nakamura, Y; Tang, Y, 2023
)
1.26

Dosage Studied

ExcerptRelevanceReference
" Using an identical dosing regimen, parallel results were observed in the effects of these isothiocyanates on O6-methylguanine formation in the lung, in which PEITC at either dose resulted in considerable inhibition at 2 or 6 h after NNK administration, while BITC or PITC had little effect."( Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
Amin, SG; Chung, FL; Hecht, SS; Morse, MA, 1989
)
0.28
" The metabolite was excreted rapidly, appearing with maximum concentrations some 2-6 h after dosing and being essentially complete 10-12 h after administration."( Studies on the metabolism and excretion of benzyl isothiocyanate in man.
Görler, K; Krumbiegel, G; Lorenz, D; Mennicke, WH; Rittmann, N, 1988
)
0.54
" However, whereas it increased the number of aberrations four-fold, it was not able to raise SCE levels by more than 50% and there was a levelling-off in the dose-response curve."( Cytotoxic and clastogenic effects of benzyl isothiocyanate towards cultured mammalian cells.
Astley, SB; Edwards, SM; Hubert, RB; Johnson, IT; Musk, SR; Stephenson, P, 1995
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antibacterial drugA drug used to treat or prevent bacterial infections.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
isothiocyanateAn organosulfur compound with the general formula R-N=C=S.
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
aromatic glucosinolate activation19
aromatic glucosinolate activation111

Protein Targets (46)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency55.51963.189029.884159.4836AID1224846
USP1 protein, partialHomo sapiens (human)Potency44.66840.031637.5844354.8130AID504865
AR proteinHomo sapiens (human)Potency49.94220.000221.22318,912.5098AID1259243; AID743035; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency2.81840.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency49.05200.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency65.52020.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency21.91070.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency63.79300.003041.611522,387.1992AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency37.16770.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency73.51490.001530.607315,848.9004AID1224849; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency55.51960.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency61.75280.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency55.03720.000229.305416,493.5996AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency62.29400.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency55.51960.001019.414170.9645AID743191
activating transcription factor 6Homo sapiens (human)Potency62.29400.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency55.51960.057821.109761.2679AID1159526; AID1159528
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency31.62280.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency39.81070.354828.065989.1251AID504847
heat shock protein beta-1Homo sapiens (human)Potency39.47820.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency24.58420.000627.21521,122.0200AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency14.00530.00798.23321,122.0200AID2546; AID2551
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency25.11890.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Cellular tumor antigen p53Homo sapiens (human)Potency69.28770.002319.595674.0614AID651631; AID720552
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency69.28770.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency69.28770.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 2B1Rattus norvegicus (Norway rat)Ki5.80000.08002.31005.8000AID624688
Macrophage migration inhibitory factorHomo sapiens (human)IC50 (µMol)0.62000.03803.09109.8000AID1198787; AID1198788; AID1384621
Macrophage migration inhibitory factorHomo sapiens (human)Ki2.54500.03802.22565.5500AID1697390; AID1799792
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)13.09210.00033.166210.0000AID1235910; AID482142; AID516896; AID516897; AID516898; AID516899
Macrophage migration inhibitory factorHomo sapiens (human)Kd2.90000.06862.69549.0400AID1697399
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)223.00000.00051.06746.3096AID1235912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (215)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (59)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (39)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (143)

Assay IDTitleYearJournalArticle
AID1198787Inhibition of human recombinant macrophage migration inhibitory factor tautomerase activity expressed in Escherichia coli DH5alpha using L-dopachrome methyl ester as substrate incubated for 5 mins prior to substrate addition measured for 2 mins by spectro2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1271567Antiproliferative activity against human LoVo/DX cells assessed as reduction in cell viability after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids.
AID412934Induction of apoptosis in human UACC-903 cells assessed as increase in caspase 3 activity after 24 hrs relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID412937Antitumor activity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as reduction in tumor size at 2.5 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID232171Ratio of glutathione S-transferase activity in tested (cottonseed oil alone + compound) to that of control (cottonseed oil alone)1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID1474557Induction of apoptosis in human LoVo/DX cells assessed as increase in caspase3/7 activity at 15 uM using Ac-DEVD-ACC as substrate pretreated for 24 hrs followed by substrate addition measured for 2 hrs by fluorescence assay relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID412936Antitumor activity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as reduction in tumor size at 0.76 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID624688Mechanism based inhibition of rat cytochrome P450 CYP2B1 measured by 7-EFC O-deethylation activity2005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
AID1105135Fungitoxic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2252 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412939Toxicity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as effect on body weight at 2.5 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID611161Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID692256Induction of p53 R280K mutant depletion in human MDA-MB-231 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105104Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 375 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412928Cytotoxicity against human T98G cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1474606Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as serum urea level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 3.8 +/- 0.3 umol/L)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474563Induction of apoptosis in human LoVo cells assessed as late apoptotic cells at 15 uM after 24 hrs by APC-Annexin-V/propidium iodide staining based flow cytometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID476673Cytotoxicity against human HepG2 cells assessed as cell viability at 50 uM after 6 hrs by MTS assay2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Enhanced Nrf2-dependent induction of glutathione in mouse embryonic fibroblasts by isoselenocyanate analog of sulforaphane.
AID412931Cytotoxicity against human UACC-903 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID624692Mechanism based inhibition of rat cytochrome P450 CYP2B1 partition ratio2005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
AID1105089In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 150 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474542Cytotoxicity against human LoVo/DX cells after 72 hrs by sulforhodamine B assay2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105139Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1501 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412927Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1105163Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 75 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1474593Hepatotoxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as liver weight at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 1.2 +/- 0.13 g)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1198788Inhibition of macrophage migration inhibitory factor tautomerase activity in human Jurkat T cells using L-dopachrome methyl ester as substrate incubated for 30 mins prior to substrate addition measured for 2 mins by spectrophotometric analysis2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1235906Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM in presence of TRPA1 antagonist HC030031 by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1474565Induction of apoptosis in human LoVo cells assessed as increase in early apoptotic cells at 15 uM after 24 hrs by APC-Annexin-V/propidium iodide staining based flow cytometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105149Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 525 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474566Induction of apoptosis in human LoVo cells assessed as necrotic cells at 15 uM after 24 hrs by APC-Annexin-V/propidium iodide staining based flow cytometric method (Rvb = 10%)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105125Fungistatic activity in Sclerotinia sclerotiorum assessed as sclerotial viability measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692257Induction of covalent cysteine modification at p53 G245C mutant in human NCI-H596 cells at 100 uM incubated for 1 hr by monochlorobimane fluorometric assay2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105164Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 38 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105090In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 75 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474567Anti-tumor activity against mouse 4T1 cells implanted in BALB/c mdb mouse assessed as tumor growth inhibition at 300 umol/kg, ip administered five times weekly measured on day 29 post cell innoculum relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105230Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 375 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105127Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474558Induction of apoptosis in human LoVo cells assessed as increase in caspase3/7 activity at 15 uM using Ac-DEVD-ACC as substrate pretreated for 24 hrs followed by substrate addition measured for 2 hrs by fluorescence assay relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1687062Inhibition of Escherichia coli MurA using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite green colorimetric assay2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID516899Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as time point of maximal current amplitude by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1474564Induction of apoptosis in human LoVo/DX cells assessed as late apoptotic cells at 15 uM after 24 hrs by APC-Annexin-V/propidium iodide staining based flow cytometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1653751Antileishmanial activity against Leishmania donovani MHOM-ET-67/L82 axenic amastigotes assessed as parasite growth inhibition at 2 to 10 ug/ml measured after 72 hrs by Alamar blue based inverted microscopy analysis relative to control2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Synthesis, in-vitro antiprotozoal activity and molecular docking study of isothiocyanate derivatives.
AID1474598Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as WBC level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 212.3 +/- 82.8 10'3/uL)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474597Anti-tumor activity against mouse 4T1 cells implanted in BALB/c mdb mouse assessed as lung metastasis at 300 umol/kg, ip administered five times weekly measured at 29 days post cell innoculum (Rvb = 56 +/- 25 No_unit)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID412930Cytotoxicity against human Caco-2 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1474594Nephrotoxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as kidney weight at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 0.136 +/- 0.006 g)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105105Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 75 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1252689Inhibition of recombinant human PTP1B catalytic domain (1 to 322 amino acid residues) using pNPP as substrate assessed as p-nitrophenolate release by spectrophotometric analysis2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates.
AID1687068Inhibition of recombinant cathepsin B (unknown origin) exopeptidase activity expressed in Escherichia coli assessed as residual activity at 100 uM using Abz-GIVRAK(Dnp)-OH as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine fo2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID75149Induction of increased cytosolic glutathione S-transferase activity in small bowel mucosa of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID1235916Effect on Ca2+ response in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105231Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 75 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105129Fungitoxic activity in Sclerotinia sclerotiorum assessed as viability in volatile phase at 225 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474541Cytotoxicity against human LoVo cells after 72 hrs by sulforhodamine B assay2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1697399Displacement of 4'-(7-Hydroxy-2-oxo-2H-chromen-3-yl)-[1,1'-biphenyl]-4-carboxylic acid from C-terminal His-tagged recombinant human MIF expressed in Escherichia coli BL21 (DE3) preincubated for 10 mins followed by probe addition and measured after 10 mins2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
7-Hydroxycoumarins Are Affinity-Based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor.
AID1235912Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1687067Inhibition of recombinant cathepsin B (unknown origin) endopeptidase activity expressed in Escherichia coli assessed as residual activity at 100 uM using Z-RR-AMC as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine followed by2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105232Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 38 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105229Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 525 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474595Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as spleen weight at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 0.603 +/- 0.133 g)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1396799Antiproliferative activity against human LoVo/DX cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 08-15, Volume: 28, Issue:15
Phosphorus-containing isothiocyanate-derived mercapturic acids as a useful alternative for parental isothiocyanates in experimental oncology.
AID1105162Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 225 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1474578Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as body weight loss at 300 umol/kg, ip administered on day 14 post cell innoculum2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474553Cell cycle arrest in human LoVo cells at 15 uM after 24 hrs by propidium iodide staining based flow cytometric method2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID75146Induction of increased cytosolic glutathione S-transferase activity in liver of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID1105103Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 751 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235910Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1235908Effect on Ca2+ response in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1474600Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as hemoglobin level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 15.1 +/- 1.5 g/dl)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID75147Induction of increased cytosolic glutathione S-transferase activity in lung of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID611159Antiproliferative activity against human T47D cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1271566Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids.
AID1105107Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 38 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692266Induction of apoptosis in human MDA-MB-231 cells expressing p53 R280K mutant at 10 uM incubated for 24 hrs by FITC/Annexin-V staining method2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1384621Inhibition of recombinant human MIF expressed in Escherichia coli BL21(DE3) using L-dopa as substrate2018Journal of medicinal chemistry, 09-27, Volume: 61, Issue:18
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.
AID692163Induction of p53 G245C mutant depletion in human NCI-H596 cells at 20 uM incubated for 2 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692162Induction of p53 G245C mutant depletion in human NCI-H596 cells at 10 uM incubated for 2 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1235911Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 100 uM ITC2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID692258Induction of conformational changes in p53 G245C mutant in human NCI-H596 cells at 60 uM incubated for 1 hr at 32 degC by tryptophan fluorescence emission spectroscopy2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105126Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687069Inhibition of recombinant cathepsin X (unknown origin) expressed in Pichia pastoris assessed as residual activity at 100 uM using Abz-Fek(Dnp)-OH as substrate preincubated for 30 mins under shaking in presence of 5 mM cysteine followed by substrate additi2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID516897Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at -30 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID1474596Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as lung weight at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 0.2 +/- 0.018 g)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1235904Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1235917Agonist activity at mouse TRPM8 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105193Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2252 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID482142Activation of TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1105197Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 525 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID75144Induction of increased cytosolic glutathione S-transferase activity in large bowel mucosa of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID412932Cytotoxicity against human UACC-903 cells assessed as decrease in cell viability after 24 hrs by MTS assay relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID679741TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, Benzylisothiocyanate: 100 uM) in MCF-7/ADR cells2002Pharmaceutical research, Oct, Volume: 19, Issue:10
Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine.
AID1517970Inhibition of human FBPase expressed in Escherichia coli BL21 (DE3) at 500 uM using FBP as substrate incubated for 5 mins by malachite green dye based spectrophotometry relative to control2019European journal of medicinal chemistry, Dec-15, Volume: 184Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
AID1235915Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM in presence of TRPV1 antagonist CPZ by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID412940Cytotoxicity against human HT1080 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1396798Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay2018Bioorganic & medicinal chemistry letters, 08-15, Volume: 28, Issue:15
Phosphorus-containing isothiocyanate-derived mercapturic acids as a useful alternative for parental isothiocyanates in experimental oncology.
AID611160Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1105196Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 676 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105161Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 375 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID611158Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1474601Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as hematocrit at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 39.9 +/- 3.7 %)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1235913Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 10 uM capsaicin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID681336TP_TRANSPORTER: cell accumulation of 0.05u daunomycin in MCF-7/ADR cells2004Journal of pharmaceutical sciences, Jul, Volume: 93, Issue:7
Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport.
AID1474599Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as RBC level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 8.6 +/- 0.9 10'6/uL)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474562Induction of apoptosis in human LoVo/DX cells assessed as loss of mitochondrial membrane potential at 15 uM after 24 hrs by JC-1 staining based flow cytometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1653750Antitrypanosomal activity against bloodstream Trypanosoma brucei rhodesiense STIB900 assessed as parasite growth inhibition at 2 ug/ml measured after 70 hrs by Alamar blue assay relative to control2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Synthesis, in-vitro antiprotozoal activity and molecular docking study of isothiocyanate derivatives.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID611162Antiproliferative activity against doxorubicin-resistant human LoVo cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1474577Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as body weight loss at 300 umol/kg, ip administered five times weekly measured on day 11 post cell innoculum2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID75142Induction of increased cytosolic glutathione S-transferase activity in forestomach of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID1105228Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 751 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235914Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID75140Induction of increased cytosolic glutathione S-transferase activity in bladder of A/J mice treated with 3 doses of 0.04 mM compound (dissolved in 0.3 mL of cottonseed oil) for 2 days1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Phenylalkyl isothiocyanate-cysteine conjugates as glutathione S-transferase stimulating agents.
AID1474604Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as serum AST level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 136 +/- 10.3 U/L)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID516898Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at 75 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID692255Induction of p53 G245C mutant depletion in human NCI-H596 cells at 20 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID412935Induction of apoptosis in human UACC-903 cells assessed as increase in caspase 7 activity after 24 hrs relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1697390Inhibition of C-terminal His-tagged recombinant human MIF expressed in Escherichia coli BL21 (DE3) using 4-HPP as substrate preincubated for 10 mins followed by substrate addition by UV absorption spectrum analysis2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
7-Hydroxycoumarins Are Affinity-Based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor.
AID1105195Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 751 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687066Inhibition of Escherichia coli MurA assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins in presence of 5 mM cysteine by malachite green co2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105160Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 751 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1574489Inhibition of recombinant His6-tagged USP7 catalytic domain (unknown origin) assessed as association constant using Ub-AMC as substrate by fluorescence assay2019Bioorganic & medicinal chemistry letters, 01-15, Volume: 29, Issue:2
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
AID1474570Anti-tumor activity against mouse 4T1 cells implanted in BALB/c mdb mouse assessed as tumor growth inhibition at 300 umol/kg, ip administered five times weekly measured on day 15 post cell innoculum relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1574521Inhibition of recombinant human N-terminal His6-tagged USP9x assessed as association constant using Cy5-UbVME as substrate preincubated for 15 mins followed by substrate addition and measured after 7 mins by fluorescence assay2019Bioorganic & medicinal chemistry letters, 01-15, Volume: 29, Issue:2
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
AID412929Cytotoxicity against human PC-3 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1474605Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as serum creatinine level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 9.3 +/- 1.2 umol/L)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474602Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as serum PLT level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 972 +/- 157 10'3/uL)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1105146Fungitoxic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 751 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1687064Inhibition of Staphylococcus aureus MurA expressed in Escherichia coli assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite gr2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1653742Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C4 trypomastigotes infected in rat L6 cells assessed as parasite growth inhibition at 2 ug/ml measured after 96 hrs by inverted microscopy analysis relative to control2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Synthesis, in-vitro antiprotozoal activity and molecular docking study of isothiocyanate derivatives.
AID1474603Toxicity in BALB/c mdb mouse implanted with mouse 4T1 cells assessed as serum ALT level at 300 umol/kg, ip administered five times weekly measured at 29 day post cell innoculum (Rvb = 23.8 +/- 2.2 U/L)2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID1474561Induction of apoptosis in human LoVo cells assessed as loss of mitochondrial membrane potential at 15 uM after 24 hrs by JC-1 staining based flow cytometric method relative to control2017European journal of medicinal chemistry, May-26, Volume: 132Novel phosphonate analogs of sulforaphane: Synthesis, in vitro and in vivo anticancer activity.
AID412933Antiproliferative activity against human UACC-903 cells assessed as BrdU incorporation after 24 hrs by ELISA relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1687065Inhibition of Escherichia coli MurA assessed as residual activity at 100 uM using UNAG and PEP as substrate preincubated for 30 mins in presence of UNAG followed by PEP addition and measured after 15 mins by malachite green colorimetric assay relative to 2018European journal of medicinal chemistry, Dec-05, Volume: 160A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
AID1105194Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1501 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID516896Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells at -75 mV holding potential by patch-clamp electrophysiology2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1799792Tautomerase Enzyme Assay from Article 10.1074/jbc.M110.113951: \\Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.\\2010The Journal of biological chemistry, Aug-20, Volume: 285, Issue:34
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (289)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (4.15)18.7374
1990's31 (10.73)18.2507
2000's75 (25.95)29.6817
2010's139 (48.10)24.3611
2020's32 (11.07)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.62 (24.57)
Research Supply Index5.69 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index56.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (2.36%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other289 (97.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]